NeurAxis, Inc. (NRXS)
7.25
+0.07
(+0.97%)
USD |
NYAM |
Apr 02, 16:00
7.21
-0.04
(-0.55%)
After-Hours: 20:00
NeurAxis EPS Diluted (Quarterly) : -0.1787 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.709M |
| Revenue (Quarterly) | 0.9681M |
| Total Expenses (Quarterly) | 2.677M |
| Enterprise Value | 76.57M |
| Gross Profit Margin (Quarterly) | 85.37% |
| Profit Margin (Quarterly) | -176.5% |
| Earnings Yield | -13.33% |
| Normalized Earnings Yield | -13.32 |